Ortigas-Wedekind Marga 4

What Happened

• Marga Ortigas-Wedekind, a director of HeartBeam, Inc. (BEAT), received a derivative award on February 9, 2026: options covering 44,827 shares of common stock. The reported acquisition price is $0.00 and the reported dollar value is $0. This was an award/grant of options (not an open-market buy or sale).

Key Details

• Transaction date: 2026-02-09; Form 4 filed: 2026-03-23 (filing was late relative to the typical 2-business-day requirement).
• Transaction type/code: Award/Grant (A); Instrument: options (derivative).
• Number of shares/options: 44,827 shares underlying the Special Option. Reported price: $0.00; reported value: $0.
• Vesting: Per footnote, the Special Option vests in two installments — half on March 31, 2026 (three-month anniversary from 1/1/2026) and the remainder on June 30, 2026 (six-month anniversary). Options were issued under the Company’s 2022 Equity Incentive Plan.
• Shares owned after the transaction: Not specified in the provided filing excerpt.
• Timeliness: This Form 4 was filed later than the usual 2-business-day window; late filings reduce transparency but do not by themselves indicate insider intent.

Context

• This was a grant of options (a derivative award). The grant does not involve an immediate purchase or sale of shares and does not produce cash proceeds until/unless the options are exercised in the future.
• Director awards are common compensation; they signal board compensation decisions but are not direct indicators of a short-term trading view.